carnitine has been researched along with endothelin-1 in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Charakida, M; Stefanadis, C; Tousoulis, D | 1 |
Anzaldi, M; Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS | 1 |
Chao, HH; Chen, CH; Cheng, TH; Lin, JW; Liu, JC; Wong, KL | 1 |
Chang, LP; Han, JK; Jia, ZH; Wang, HT; Wei, C; Wu, YL | 1 |
Aggarwal, S; Black, SM; Dasarathy, S; Fineman, JR; Gross, C; Han, W; Hou, Y; Kumar, S; Lee, SG; Lu, Q; Meadows, ML; Rafikova, O; Sharma, S; Su, Y; Sun, X | 1 |
Adamski, J; Chaykovska, L; Hocher, B; Kalk, P; Krause-Relle, K; Kretschmer, A; Pfab, T; Reichetzeder, C; Stasch, JP; Tsuprykov, O | 1 |
1 review(s) available for carnitine and endothelin-1
Article | Year |
---|---|
Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
Topics: Animals; Apoptosis; Carnitine; Cell Adhesion Molecules; Endothelin-1; Endothelium, Vascular; Exercise; Heart Failure; Humans; Inflammation; Nitric Oxide; Tumor Necrosis Factor-alpha | 2005 |
1 trial(s) available for carnitine and endothelin-1
Article | Year |
---|---|
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
Topics: Ankle; Branchial Region; Carnitine; Double-Blind Method; Endothelin-1; Homocysteine; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Peripheral Vascular Diseases; Placebos; Renal Dialysis | 2006 |
4 other study(ies) available for carnitine and endothelin-1
Article | Year |
---|---|
L-Carnitine attenuates angiotensin II-induced proliferation of cardiac fibroblasts: role of NADPH oxidase inhibition and decreased sphingosine-1-phosphate generation.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiotonic Agents; Carnitine; Cell Proliferation; Cells, Cultured; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Gene Expression Regulation; Heart; Lysophospholipids; Myocardium; NADPH Oxidases; Osmolar Concentration; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Signal Transduction; Sphingosine; Transcription Factor AP-1 | 2010 |
[Effects of fatigue and restraint stress on the expression of carnitine palmitoyltransferase-I and 5-hydroxytryptamine receptors in aorta of rats].
Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Endothelial Cells; Endothelin-1; Fatigue; Male; Nitric Oxide; PPAR gamma; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT2A; Restraint, Physical; Serotonin; Stress, Psychological | 2011 |
Endothelin-1 induces a glycolytic switch in pulmonary arterial endothelial cells via the mitochondrial translocation of endothelial nitric oxide synthase.
Topics: Adenosine Triphosphate; Animals; Carnitine; Cell Membrane; Cells, Cultured; Endothelial Cells; Endothelin-1; Glycolysis; Mitochondria; Nitric Oxide Synthase Type III; Phosphorylation; Protein Kinase C-delta; Pulmonary Artery; Rats; Reactive Oxygen Species; Signal Transduction | 2014 |
Endothelin-1 Overexpression Improves Renal Function in eNOS Knockout Mice.
Topics: Albumins; Animals; Blood Pressure; Carnitine; Collagen Type I; Collagen Type I, alpha 1 Chain; Connective Tissue Growth Factor; Cystatin C; Endothelin-1; Fatty Acid Binding Protein 3; Fatty Acid-Binding Proteins; Female; Humans; Kidney; Male; Mice; Mice, Knockout; Mice, Transgenic; Mitochondria; Nitric Oxide; Nitric Oxide Synthase Type III; Osteopontin; Tissue Inhibitor of Metalloproteinase-1 | 2015 |